ANG-2 |
Angiopoietin-2 |
BC |
Breast cancer |
CRC |
Colorectal cancer |
CTLA-4 |
Cytotoxic T-lymphocyte associated protein 4 |
CXCL10 |
CXC-chemokine ligand 10 |
CXCR3+ |
C-X-C motif chemokine receptor 3 |
DC |
Dendritic cells |
EMA |
European Medial Agency |
FGF |
Fibroblast growth factor |
FLT3 |
Fms-like tyrosine kinase-3 receptor |
HCC |
Hepatocellular carcinoma |
HIF-1 |
Hypoxia-inducible factor 1 |
HSPG |
Heparan sulfate proteoglycans |
ICAM1 |
Intracellular adhesion molecule 1 |
MAPK |
Mitogen-activated protein kinase |
MC |
Mast cells |
MDSC |
Myeloid-derived suppressor cell |
MMP-9 |
Metallopeptidase 9 |
NF-κB |
Nuclear factor-kappa B |
NK |
Natural killer |
NRP |
Neuropilin |
NSCLC |
Non-small cell lung cancer |
OC |
Ovarian cancer |
OS |
Overall survival |
PD-1 |
Programmed cell death 1 |
PDGF |
Platelet-derived growth factor |
PFS |
Progression-free survival |
PI3K |
Phosphoinositide-3-kinase |
PKB |
Protein kinase B |
PKC |
Protein kinase C |
PLCγ |
Phospholipase-Cγ |
PlGF |
Placental growth factor |
RCC |
Renal cell carcinoma |
SCC |
Squamous cell carcinoma |
TAM |
Tumor-associated macrophage |
TGF-β |
Transforming growth factor β |
TIM-3 |
T cell immunoglobulin and mucin-domain containing-3 |
TKI |
Tyrosine kinase inhibitors |
TME |
Tumor microenvironment |
TNFα |
Tumor necrosis factor-α |
VCAM1 |
Vascular cell adhesion protein 1 |
VEGF |
Vascular endothelial growth factor |
VEGFR |
Vascular endothelial growth factor receptors |